About
Orlucent develops a handheld fluorescent molecular imaging system that non-invasively evaluates early tissue remodeling in moles to assess their likelihood of transitioning to melanoma.
Explore Orlucent's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.